Evidence map›Paper›PMID 42440684›Full record

ArticleAdvances in urology2026

Zachary Stanton, Bonnie Woloschuk, Alexander Tamm, Ryan Hung, Adwait Trivedi, Michael Kolinsky, Nawaid Usmani, Lindsay Rowe, Ronald Moore, Frank Wuest and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advances in urology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zachary StantonDepartment of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Bonnie WoloschukDepartment of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Alexander TammDepartment of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Ryan HungDepartment of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.ORCID https://orcid.org/0000-0001-5710-1476
Adwait TrivediDepartment of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Michael KolinskyDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Nawaid UsmaniDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Lindsay RoweDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Ronald MooreDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Frank WuestDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
Jonathan AbeleDepartment of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.ORCID https://orcid.org/0000-0002-5311-1332

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The goal of this study was to compare the accuracy of Methods: This prospective nonrandomized Phase II cohort study clinical trial included 85 patients with biochemically recurrent prostate cancer (previous therapy). Results: 53 patients with a total of 72 evaluable lesions were included in the analysis. Conclusion: Overall, the findings support the use of

Indexed as

biochemical recurrencebone scanCTPET/CTprostate cancerPSMA-1007

Identifiers

PMID42440684
PMCPMC13333931

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.